[A case of mixed connective tissue disease developed into overlap syndrome of progressive systemic sclerosis, systemic lupus erythematosus, polymyositis and Sjögren's syndrome]. 1990

Y Akiyama, and T Suzuki, and M Tanaka, and K Kobayashi, and T Kagiri, and T Ishibashi, and H Kitagawa, and F Imai, and K Hara, and Y Doi
Second Department of Internal Medicine, Saitama Medical School.

We encountered a patient who developed an overlap syndrome of progressive systemic sclerosis (PSS), systemic lupus erythematosus (SLE), polymyositis (PM) and Sjögren's syndrome (SjS) while we were treating her for mixed connective tissue disease (MCTD). This 42-year-old woman had been photosensitive since 18 years of age. In 1986, Raynaud's phenomenon, swollen hands and arthralgia appeared; therefore, we started to treat this patient based on a diagnosis of MCTD. At that time, her anti-RNP antibody titer was 82,920, but she was negative to anti-Sm antibody. In 1988, she was admitted to our hospital with chief complaints of aggravation of polyarthralgia and myalgia. On physical examination, she showed difficulty in opening her mouth, systemic dermal sclerosis, a decrease in muscular strength and rales. In laboratory tests, her myogenic enzyme level was increased, and she was found to be positive to LE cells, antinuclear antibody, anti-DNA antibody, anti-ENA antibody and anti-SSA antibody. Furthermore, histological features clearly corresponding to those of PSS were found by skin biopsy, myogenic changes by electromyography, evidence of chronic inflammation of the salivary glands by lip biopsy, and proliferative changes in the mesangium were detected by renal biopsy. The concept of MCTD, especially the differences from overlap syndrome, is vague. Therefore we need further study about many cases. Since there have been no reports on cases having sufficient evidence of the development of the overlap syndrome of PSS, SLE, PM and SjS during a course of MCTD, our patient would provide very useful data contributing to the study of MCTD.

UI MeSH Term Description Entries
D008046 Lip Either of the two fleshy, full-blooded margins of the mouth. Philtrum,Lips,Philtrums
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008947 Mixed Connective Tissue Disease A syndrome with overlapping clinical features of systemic lupus erythematosus, scleroderma, polymyositis, and Raynaud's phenomenon. The disease is differentially characterized by high serum titers of antibodies to ribonuclease-sensitive extractable (saline soluble) nuclear antigen and a "speckled" epidermal nuclear staining pattern on direct immunofluorescence. Connective Tissue Disease, Mixed,Sharp Syndrome,MCTD,Syndrome, Sharp
D009220 Myositis Inflammation of a muscle or muscle tissue. Inflammatory Myopathy,Myositis, Focal,Myositis, Infectious,Idiopathic Inflammatory Myopathies,Idiopathic Inflammatory Myopathy,Idiopathic Inflammatory Myositis,Infectious Myositis,Inflammatory Muscle Diseases,Inflammatory Myopathies, Idiopathic,Inflammatory Myopathy, Idiopathic,Muscle Diseases, Inflammatory,Myopathies, Idiopathic Inflammatory,Myopathy, Inflammatory,Myositis, Proliferative,Focal Myositides,Focal Myositis,Infectious Myositides,Inflammatory Muscle Disease,Inflammatory Myopathies,Muscle Disease, Inflammatory,Myopathies, Inflammatory,Myopathy, Idiopathic Inflammatory,Myositides,Myositides, Focal,Myositides, Infectious,Myositides, Proliferative,Proliferative Myositides,Proliferative Myositis
D004576 Electromyography Recording of the changes in electric potential of muscle by means of surface or needle electrodes. Electromyogram,Surface Electromyography,Electromyograms,Electromyographies,Electromyographies, Surface,Electromyography, Surface,Surface Electromyographies
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000974 Antibodies, Antinuclear Autoantibodies directed against various nuclear antigens including DNA, RNA, histones, acidic nuclear proteins, or complexes of these molecular elements. Antinuclear antibodies are found in systemic autoimmune diseases including systemic lupus erythematosus, Sjogren's syndrome, scleroderma, polymyositis, and mixed connective tissue disease. Anti-DNA Antibodies,Antibodies, Anti-DNA,Antinuclear Antibodies,Antinuclear Autoantibodies,Antinuclear Autoantibody,Antinuclear Factors,Antinuclear Antibody,Antinuclear Factor,Anti DNA Antibodies,Antibody, Antinuclear,Autoantibody, Antinuclear,Factor, Antinuclear
D012595 Scleroderma, Systemic A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA. Sclerosis, Systemic,Systemic Scleroderma,Systemic Sclerosis

Related Publications

Y Akiyama, and T Suzuki, and M Tanaka, and K Kobayashi, and T Kagiri, and T Ishibashi, and H Kitagawa, and F Imai, and K Hara, and Y Doi
April 2018, Seminars in musculoskeletal radiology,
Y Akiyama, and T Suzuki, and M Tanaka, and K Kobayashi, and T Kagiri, and T Ishibashi, and H Kitagawa, and F Imai, and K Hara, and Y Doi
January 2007, Acta reumatologica portuguesa,
Y Akiyama, and T Suzuki, and M Tanaka, and K Kobayashi, and T Kagiri, and T Ishibashi, and H Kitagawa, and F Imai, and K Hara, and Y Doi
August 1976, Radiology,
Y Akiyama, and T Suzuki, and M Tanaka, and K Kobayashi, and T Kagiri, and T Ishibashi, and H Kitagawa, and F Imai, and K Hara, and Y Doi
February 1989, The American journal of cardiology,
Y Akiyama, and T Suzuki, and M Tanaka, and K Kobayashi, and T Kagiri, and T Ishibashi, and H Kitagawa, and F Imai, and K Hara, and Y Doi
July 2006, Rheumatology international,
Y Akiyama, and T Suzuki, and M Tanaka, and K Kobayashi, and T Kagiri, and T Ishibashi, and H Kitagawa, and F Imai, and K Hara, and Y Doi
April 1979, The Medical journal of Australia,
Y Akiyama, and T Suzuki, and M Tanaka, and K Kobayashi, and T Kagiri, and T Ishibashi, and H Kitagawa, and F Imai, and K Hara, and Y Doi
January 2014, Handbook of clinical neurology,
Y Akiyama, and T Suzuki, and M Tanaka, and K Kobayashi, and T Kagiri, and T Ishibashi, and H Kitagawa, and F Imai, and K Hara, and Y Doi
September 2022, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...,
Y Akiyama, and T Suzuki, and M Tanaka, and K Kobayashi, and T Kagiri, and T Ishibashi, and H Kitagawa, and F Imai, and K Hara, and Y Doi
June 2023, Modern rheumatology case reports,
Y Akiyama, and T Suzuki, and M Tanaka, and K Kobayashi, and T Kagiri, and T Ishibashi, and H Kitagawa, and F Imai, and K Hara, and Y Doi
January 2015, Current health sciences journal,
Copied contents to your clipboard!